OMX30 1 490 -0,8%  OMXH25 3 915 -1,0%  Bitcoin 5 612,28 -1,1%  Dow 25 289 0,8%  Nas 6 890 1,8%  EUR 10,2645 0,0%  USD 9,0418 -0,3%  Olja 67,2 0,9%  Guld 1 216 0,2% 

Ipsen Aktie

121,80EUR -0,05EUR -0,04%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
Obligationer
>

Fundamentala nyckeltal för Ipsen

2017 2018e 2019e 2020e 2021e
Utdelning 0,87 1,14 1,29 1,49 1,80
Direktavkastning (i %) 0,86 0,94 1,06 1,22 1,47
PE-tal 23,27 21,58 17,79 15,12 12,74
Resultat/aktie 4,36 5,65 6,85 8,06 9,58

Nyheter om Ipsen

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Ipsen

ytterligare analyser

Ipsen Peer Group

Ipsen 121,80
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Ipsentill bolagsprofilen

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care and Consumer Healthcare. The Specialty Care segment focuses on Oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and Rare Diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The Consumer Healthcare segment include brands such as Smecta, a naturally extracted purified clay for the symptomatic treatment of acute diarrhea; Tanakan, a standardized extract from the leaves of Ginkgo biloba for the treatment of various neurological and neuro-sens or ial disorders; Forlax, an osmotic laxative indicated for the symptomatic treatment of constipation in adults and children; and Fortrans, a colon cleansing solution indicated for patients in preparation for endoscopic, radiological examinations or colonic surgery. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Realtidskurs Ipsen

Bid 122,15 EUR Ask 122,75 EUR
Kurstid 08:15 Börsen STU

Aktiekurs Ipsen i EURPUSH CHART

Kurs 121,80 EUR -0,05 -0,04 %
Kurstid 17:35:03
Datum 15.11.2018
Öppning 0,00
Gårdagen 121,85
Dagshögsta 0,00
Dagslägsta 0,00
52 v. högsta 155,95
52 v. lägsta 97,24
52 v. perf.
Volym (Antal) 0
Börsvärde (SEK) 104,89 Mrd
Börsen
Kurs för 121,80 EUR från börsen Paris motsvarar med aktuell växelkurssentspricht EUR/SEK en kurs på 1 250,22 SEK.

Till aktien Ipsen

Ticker
ISIN FR0010259150
Index CAC MID 60, SBF 120

Ipsen Nyckeltal

Börsvärde i SEK 104,89 Mrd
Free float %
Antal aktier mio. 83,79
Cashflow/aktie i lokal valuta 4,93
Bokvärde/aktie i lokal valuta 18,38
60 dagar vola 24,48
PBV

Ipsen Historiska kurser

2018-11-15 121,80 98 528
2018-11-14 121,85 66 671
2018-11-13 122,20 122 574
2018-11-12 123,00 96 864
2018-11-09 127,50 85 562